Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

Body Weight Changes Clinical Trial

Official title:

Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02966444
• Other study ID #: CT2016JS1
• Status: Recruiting
• Phase: N/A
• Start date: October 2016
• Est. completion date: July 2018

Study information

• Verified date: July 2018
• Source: Texas Christian University
• Contact: Jada L Stevenson, PhD
• Phone: 817-257-6310
• Email: jada.stevenson[@]tcu.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the effects of dietary fatty acid composition from high fat meals on markers of hunger, satiety and metabolism.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 16
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• BMI of >18.5-24.9kg/m2

• Woman

• 18-40yrs of age

Exclusion Criteria:

• Evidence of weight loss or gain exceeding 5% of their body weight within the past 3 months.

• Plans to lose weight or begin a weight loss program between initiation of study and final testing.

• Plans to begin an exercise program or change current exercise routines between initiation of study and final testing.

• Is on a medically prescribed diet

• Does not consume breakfast regularly

• Rate less than 80% of foods offered in the buffet at 50mm or more on the 100mm VAS as palatable

• Medications that could influence appetite or sensory function

• Reports of metabolic or endocrine disease, gastrointestinal disorders, or history of medical or surgical events that could affect fat digestion and hormone signaling.

• Any chronic disease including type II diabetes, hypothyroidism, hyperthyroidism, cardiovascular disease, and cancer

• Any supplements that a subject begins taking between initiation of study and final testing.

• Anyone who is currently pregnant, lactating, or planning on becoming pregnant before the conclusion of this study.

• Anyone who has allergies to any of the components of the liquid meals

• Anyone who has donated blood in the last 20 days

Related Conditions & MeSH terms

• Body Weight
• Body Weight Changes

Intervention

Other:
• MUFA-rich HF Meal

• PUFA-rich HF Meal

• SFA-rich HF Meal

Locations

Country	Name	City	State
United States	Texas Christian University	Fort Worth	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Texas Christian University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Peptide-YY		18 months
Secondary	Visual Analog Scale		18 months